醫藥級氯化鈉的全球市場

Pharmaceutical Grade Sodium Chloride

出版日期: 2024年08月28日 | 出版商:

Global Industry Analysts, Inc. | 英文 102 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

至2030年，全球醫藥級氯化鈉市場預計將達到9.737億美元

2023 年全球醫藥級氯化鈉市場預計為 6.648 億美元，預計到 2030 年將達到 9.737 億美元，2023-2030 年分析期間複合年成長率為 5.6%。透析最終用途是本報告分析的細分市場之一，預計複合年成長率為 6.0%，到分析期結束時將達到 4.175 億美元。分析期內，注射最終用途產業的複合年成長率預計為 6.3%。

美國市場預估為1.793億美元，中國預期複合年成長率為5.1%

預計2023年美國醫藥級氯化鈉市場規模為1.793億美元。中國作為全球第二大經濟體，預計2030年市場規模將達1.515億美元，2023年至2030年複合年成長率為5.1%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.8% 和 4.6%。在歐洲，德國的複合年成長率預計為 4.2%。

全球醫藥級氯化鈉市場－主要趨勢與促進因素總結

確保純度：醫藥級氯化鈉的關鍵作用

藥用級氯化鈉，俗稱食鹽，是用於醫療和製藥目的的高精製氯化鈉。與普通食鹽不同，此等級的氯化鈉不含污染物和雜質，可確保敏感應用的安全性和有效性。氯化鈉在多種藥物製劑中發揮重要作用，包括靜脈生理食鹽水、口服補液鹽和注射稀釋劑。醫藥級氯化鈉的純度和一致性對於確保醫藥產品符合嚴格的監管標準並提供有效的治療至關重要。其應用範圍從透析液、創傷護理產品，甚至鼻腔清洗，凸顯了其在現代醫療保健中的多功能性和不可或缺性。

技術進步如何提高藥用氯化鈉的品質？

科技的進步大大提高了醫藥級氯化鈉的生產和品管。先進的結晶和薄膜過濾等精製技術，增強了雜質的去除，確保氯化鈉的高純度，符合世界各地藥典的嚴格標準。引進高效液相層析（HPLC）和原子吸收光譜（AAS）等先進分析方法，能準確監測雜質含量，確保一致性和安全性。此外，製造過程的自動化可以最大限度地減少人為錯誤並提高生產效率。這些技術進步不僅確保了藥用氯化鈉的高品質，而且能夠實現大規模生產，以滿足醫療保健領域不斷成長的需求。

藥用氯化鈉有哪些法規和安全標準？

醫藥級氯化鈉遵循嚴格的監管和安全標準，以確保其適合醫療用途。美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等監管機構對這項重要成分的製造、測試和標籤制定了嚴格的指導方針。必須遵守美國藥典 (USP) 和歐洲藥典 (Ph.Eur.) 等藥典標準。這些標準規定了可接受的雜質水平、微生物極限以及所需的物理和化學特性。製造商還必須遵守良好生產規範 (GMP)，其中包括品管系統、衛生標準和文件程序。遵守這些嚴格的規定可確保醫藥級氯化鈉在醫療應用中安全使用並符合最高品質標準。

推動醫藥級氯化鈉市場成長的因素有哪些？

醫藥級氯化鈉市場的成長受到多種因素的推動。首先，糖尿病和腎臟病等慢性疾病的增加增加了對靜脈注射生理食鹽水和透析治療的需求，而這需要高純度的氯化鈉。精製和製造流程的技術進步正在提高產品品質並擴大生產能力，以滿足不斷成長的醫療保健需求。此外，世界人口的老化正在增加對使用藥用級氯化鈉的各種治療的需求。生物製藥行業的擴張需要高品質的藥物配方和生產原料，這進一步推動了市場的成長。此外，嚴格的監管標準使製造商能夠持續改進其生產流程和品管，以確保安全有效地供應醫藥級氯化鈉。最後，對個人化醫療和先進給藥系統的日益關注正在為藥用氯化鈉的特殊用途創造新的機會，刺激市場擴張。

受訪企業範例（12家知名企業）

Akzo Nobel NV
Dominion Salt Ltd.
Hebei Huachen Pharmaceutical Co., Ltd.
K+S France SAS
Morton Salt, Inc.
Salinen Austria Aktiengesellschaft
Sudwestdeutsche Salzwerke AG
Swiss Saltworks
Tianjin Changlu Haijing Group Co., Ltd.
US Salt, LLC.

The global market for Pharmaceutical Grade Sodium Chloride estimated at US$664.8 Million in the year 2023, is expected to reach US$973.7 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Dialysis End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$417.5 Million by the end of the analysis period. Growth in the Injections End-Use segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$179.3 Million While China is Forecast to Grow at 5.1% CAGR

The Pharmaceutical Grade Sodium Chloride market in the U.S. is estimated at US$179.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$151.5 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Pharmaceutical Grade Sodium Chloride Market - Key Trends and Drivers Summarized

Ensuring Purity: The Essential Role of Pharmaceutical Grade Sodium Chloride

Pharmaceutical grade sodium chloride, commonly known as salt, is a highly purified form of sodium chloride used in medical and pharmaceutical applications. Unlike regular table salt, this grade of sodium chloride is free from contaminants and impurities, ensuring its safety and efficacy in sensitive applications. It plays a critical role in various pharmaceutical formulations, including intravenous (IV) saline solutions, oral rehydration salts, and as a diluent for injectable drugs. The purity and consistency of pharmaceutical grade sodium chloride are paramount as they ensure that medications meet stringent regulatory standards and provide effective treatment. Its use extends to dialysis solutions, wound care products, and even as a nasal rinse, highlighting its versatility and indispensability in modern healthcare.

How Are Technological Advancements Enhancing the Quality of Pharmaceutical Sodium Chloride?

Technological advancements have significantly improved the production and quality control of pharmaceutical grade sodium chloride. Advanced purification techniques, such as recrystallization and membrane filtration, have enhanced the removal of impurities, ensuring high-purity sodium chloride that meets the stringent standards of pharmacopeias worldwide. The implementation of sophisticated analytical methods, including high-performance liquid chromatography (HPLC) and atomic absorption spectroscopy (AAS), allows for precise monitoring of impurity levels, ensuring consistency and safety. Furthermore, automation in manufacturing processes has minimized human error and increased production efficiency. These technological strides not only ensure the high quality of pharmaceutical sodium chloride but also enable large-scale production to meet the growing demand in the healthcare sector.

What Are the Regulatory and Safety Standards Governing Pharmaceutical Sodium Chloride?

Pharmaceutical grade sodium chloride is subject to rigorous regulatory and safety standards to ensure its suitability for medical use. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict guidelines on the production, testing, and labeling of this critical ingredient. Compliance with pharmacopeial standards, such as the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.), is mandatory. These standards specify the acceptable levels of impurities, microbial limits, and the required physical and chemical properties. Manufacturers must also adhere to Good Manufacturing Practices (GMP), which encompass quality management systems, hygiene standards, and documentation procedures. The adherence to these stringent regulations ensures that pharmaceutical grade sodium chloride is safe for use in medical applications and meets the highest quality standards.

What Factors Are Driving Growth in the Pharmaceutical Grade Sodium Chloride Market?

The growth in the pharmaceutical grade sodium chloride market is driven by several factors. Firstly, the increasing prevalence of chronic diseases such as diabetes and kidney disorders is boosting the demand for IV saline solutions and dialysis treatments, where high-purity sodium chloride is essential. Technological advancements in purification and manufacturing processes are enhancing product quality and expanding production capacity, meeting the rising healthcare needs. Additionally, the aging global population is contributing to higher demand for various medical treatments that utilize pharmaceutical grade sodium chloride. The expansion of the biopharmaceutical sector, which requires high-quality raw materials for drug formulation and production, is further propelling market growth. Furthermore, stringent regulatory standards are driving manufacturers to continuously improve their production processes and quality controls, ensuring the supply of safe and effective pharmaceutical grade sodium chloride. Lastly, the increasing focus on personalized medicine and advanced drug delivery systems is creating new opportunities for specialized applications of pharmaceutical sodium chloride, fueling market expansion.

Select Competitors (Total 12 Featured) -

Akzo Nobel NV
Dominion Salt Ltd.
Hebei Huachen Pharmaceutical Co., Ltd.
K+S France S.A.S.
Morton Salt, Inc.
Salinen Austria Aktiengesellschaft
Sudwestdeutsche Salzwerke AG
Swiss Saltworks
Tianjin Changlu Haijing Group Co., Ltd.
US Salt, LLC.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Pharmaceutical Grade Sodium Chloride - Global Key Competitors Percentage Market Share in 2024 (E)
- Global Economic Update
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Increasing Demand for Injectable Drugs Drives Market Growth
- Rising Use of Sodium Chloride in Dialysis Solutions Expands Market Opportunity
- Growth in IV Fluid Market Propels Demand for Pharmaceutical Grade Sodium Chloride
- Advances in Purification Technologies Enhance Product Quality
- Increasing Investment in Healthcare Infrastructure
- Development of Biopharmaceuticals and Biosimilars
- Expansion of Global Pharmaceutical Manufacturing
- Rising Focus on Drug Formulation and Stability
- Growth in Clinical Research and Trials
- Increasing Applications in Oral Rehydration Solutions
- Advances in Drug Delivery Systems Impacting Sodium Chloride Usage
- Growth in Emerging Markets Expands Addressable Market Opportunity
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Oral Rehydration Salts (ORS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 15: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 16: World Pharmaceutical Grade Sodium Chloride Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 17: USA Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 18: USA Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 19: USA 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
- TABLE 20: Canada Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 21: Canada Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 22: Canada 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
- Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 23: Japan Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 24: Japan Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 25: Japan 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
- Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 26: China Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 27: China Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 28: China 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
- Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 29: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 30: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 31: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 32: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 33: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 34: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
- Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 35: France Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 36: France Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 37: France 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
- Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 38: Germany Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 39: Germany Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 40: Germany 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
- TABLE 41: Italy Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 42: Italy Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 43: Italy 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 44: UK Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 45: UK Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 46: UK 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 48: Rest of Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 49: Rest of Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 51: Asia-Pacific Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 52: Asia-Pacific 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
- TABLE 53: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 54: Rest of World Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 55: Rest of World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030